Search Within

Karlo Perica

Formats
  1. Meeting Abstract (8)
  2. Journal Article (7)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Hematology-Oncology Fellows (18)
  4. Center for Hematologic Malignancies (17)
  5. GSK Faculty (14)
  6. Hematologic Malignancies Research (14)

More Groups

People
  1. Michel Sadelain (12)
  2. Jae Park (5)
  3. Kevin Curran (5)
  4. Jessica Flynn (4)
  5. Sergio Giralt (4)
  6. Anton Dobrin (3)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (2)
  6. 2019 (1)

More Years

Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Blood Advances (1)
  4. Cell Stem Cell (1)
  5. European Journal of Immunology (1)
  6. Human Gene Therapy (1)

More Publications

Publishers
  1. Nature Publishing Group (5)
  2. American Society of Hematology (4)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)
  6. Mary Ann Liebert, Inc (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic ablation of adhesion ligands effectively averts rejection of allogeneic immune cells
    Meeting Abstract

    Hammer, Q.; Perica, K.; Mbofung, R. M.; Van Ooijen, H.; Goodridge, J. P.; Valamehr, B.; Önfelt, B.; Sadelain, M.; Malmberg, K. J.
    European Journal of Immunology (2022)

    Fulltext@MSK | Save
  • Clinical implications of T cell exhaustion for cancer immunotherapy
    Review

    Chow, A.; Perica, K.; Klebanoff, C. A.; Wolchok, J. D.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
    Journal Article

    Chung, D. J.; Sharma, S.; Rangesa, M.; DeWolf, S.; Elhanati, Y.; Perica, K.; Young, J. W.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia
    Journal Article

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Building a CAR garage: Preparing for the delivery of commercial CAR T cell products at Memorial Sloan Kettering Cancer Center
    Journal Article

    Perica, K.; Curran, K. J.; Brentjens, R. J.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save